Department of Psychiatry, Korea University College of Medicine, Seoul, Korea.
CNS Drugs. 2013 May;27 Suppl 1:S53-7. doi: 10.1007/s40263-012-0034-x.
Various clinical issues are involved in the appropriate diagnosis and proper treatment interventions for patients with major depressive disorder (MDD). Despite a number of diverse antidepressants for treating MDD now, response and remission rates following adequate trials of antidepressant intervention are still not satisfactory. Furthermore, a significant proportion of MDD patients have residual symptoms, which are associated with increased relapse and recurrence of MDD, leading to negative impacts on the clinical course and outcomes of MDD. Timely and appropriate decision-making regarding the proper management of such cases is required in our routine daily practice. These issues are illustrated and also framed by one MDD case with a complicated clinical course. This review paper may give physicians clinical insight into how we can effectively and properly evaluate and manage such patients in clinical practice.
各种临床问题都涉及到对重度抑郁症(MDD)患者的正确诊断和适当治疗干预。尽管现在有许多不同的抗抑郁药可用于治疗 MDD,但经过充分的抗抑郁药干预试验后,患者的反应率和缓解率仍然不尽如人意。此外,相当一部分 MDD 患者仍有残留症状,这与 MDD 的复发和再发率增加有关,从而对 MDD 的临床病程和结局产生负面影响。在我们的日常临床实践中,需要及时、适当地做出决策,对这类病例进行适当的管理。一个具有复杂临床病程的 MDD 病例说明了这些问题,并对这些问题进行了阐述。这篇综述文章可能会为医生提供临床见解,了解我们如何在临床实践中有效地、恰当地评估和管理此类患者。